目的:觀察口服伊曲康唑治療皮膚淺部真菌感染的療效及安全性。方法: 選擇200例臨床及真菌學確診皮膚淺部真菌感染患者,分為手足癬和體股癬治療組。手足癬組口服伊曲康唑200mg,bid;體股癬組口服200mg,qd,均連服7天,停藥3周后評價療效。結果: 手足癬治療組痊愈率、總有效率和真菌清除率分別為59.38%、82.81%和92%;體股癬治療組分別為68.06%、87.50%和94%。總不良反應發生率為5.5%。結論: 口服伊曲康唑治療皮膚淺部真菌病臨床療效好,可靠安全。
Citation: WEI Wennan,ZHU Lan,GU Peng. Oral Itraconazole for Superficial Dermatomycosis: A Clinical Series of 200 Patients. West China Medical Journal, 2009, 24(9): 2354-2355. doi: Copy
Copyright ? the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved

